Education
About Us
Working with TipRanks
Follow Us
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 152.35M | kr 198.70M | kr 238.73M | kr 57.62M | kr 11.53M |
| Gross Profit | kr 74.94M | kr 180.47M | kr 35.39M | kr 41.04M | kr -684.00K |
| Operating Income | kr -31.10M | kr -217.92M | kr -310.43M | kr -166.22M | kr -180.40M |
| EBITDA | kr -16.50M | kr -181.97M | kr -282.03M | kr -149.34M | kr -167.59M |
| Net Income | kr 127.24M | kr -266.22M | kr -388.17M | kr -172.23M | kr -191.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 86.59M | kr 124.33M | kr 65.40M | kr 193.99M | kr 295.18M |
| Total Assets | kr 671.62M | kr 842.43M | kr 653.51M | kr 690.51M | kr 688.43M |
| Total Debt | kr 58.31M | kr 191.72M | kr 231.48M | kr 38.22M | kr 44.38M |
| Net Debt | kr -28.28M | kr 67.39M | kr 166.08M | kr -155.77M | kr -250.80M |
| Total Liabilities | kr 110.97M | kr 633.89M | kr 482.17M | kr 265.63M | kr 256.69M |
| Stockholders' Equity | kr 560.65M | kr 208.54M | kr 171.34M | kr 424.89M | kr 431.74M |
| Cash Flow | |||||
| Free Cash Flow | kr -250.69M | kr -185.97M | kr -423.45M | kr -254.04M | kr -296.96M |
| Operating Cash Flow | kr -250.69M | kr -133.73M | kr -406.68M | kr -193.92M | kr -219.61M |
| Investing Cash Flow | kr -37.14M | kr -52.25M | kr -16.77M | kr -60.13M | kr -77.35M |
| Financing Cash Flow | kr 255.60M | kr 243.62M | kr 298.70M | kr 148.86M | kr 349.37M |